0001724741-19-000001.txt : 20191007 0001724741-19-000001.hdr.sgml : 20191007 20191007153718 ACCESSION NUMBER: 0001724741-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191007 DATE AS OF CHANGE: 20191007 EFFECTIVENESS DATE: 20191007 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EpiVax Oncology, Inc. CENTRAL INDEX KEY: 0001724741 IRS NUMBER: 815453645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-350504 FILM NUMBER: 191140825 BUSINESS ADDRESS: STREET 1: 146 CLIFFORD STREET CITY: PROVIDENCE STATE: RI ZIP: 02903 BUSINESS PHONE: (401)272-2123 MAIL ADDRESS: STREET 1: 146 CLIFFORD STREET CITY: PROVIDENCE STATE: RI ZIP: 02903 D 1 primary_doc.xml X0708 D LIVE 0001724741 EpiVax Oncology, Inc. 180 Varick Street Suite 665 New York NY NEW YORK 10014 6469122525 DELAWARE None None Corporation true 2017 Gad Berdugo 180 Varick Street Suite 665 New York NY NEW YORK 10014 Executive Officer Director William Martin 188 Valley Street Suite 424 Providence RI RHODE ISLAND 02909 Executive Officer Clifford Grimm 188 Valley Street Suite 424 Providence RI RHODE ISLAND 02909 Executive Officer Anne De Groot 188 Valley Street Suite 424 Providence RI RHODE ISLAND 02909 Executive Officer Director Daniel Adams 188 Valley Street Suite 424 Providence RI RHODE ISLAND 02909 Director Biotechnology Decline to Disclose 06b false 2019-08-27 false true true false 1 1250000 375000 875000 false 5 0 true 0 true 0 true false EpiVax Oncology, Inc. /s/ Gad Berdugo Gad Berdugo CEO 2019-10-07